Molecular therapy set to protect at-risk patients against heart attack and stroke

Even a single dose of a specific ribonucleic acid molecule, known as a small interfering RNA (siRNA), offers patients at high risk of cardiovascular disease long-lasting protection against high LDL cholesterol — one of the main risk factors for heart attack and stroke — conclude researchers.

Leave a Reply

Your email address will not be published. Required fields are marked *